FDA Logo links to FDA home page
Center for Biologics Evaluation and Research, U.S. Food and Drug AdministrationU.S. Food and Drug AdministrationCenter for Biologics Evaluation and Research
 HHS Logo links to Department of Health and Human Services website

FDA Home Page | CBER A-Z Index | CBER Search | Contact CBER | CBER Home Page

horizontal rule
CBER links to product areas Blood Vaccines Cellular/Gene Therapy Tissue Devices
CBER links Products Industry Healthcare Reading Room Meetings What's New
horizontal rule

List of CBER Type 1 Master Files to be Closed
Effective July 10, 2000

horizontal rule

In the Federal Register of January 12, 2000 (65FR1776), the Food and Drug Administration (FDA) published a final rule removing the provision for submitting Type I drug master files (DMFs). This rule is intended to eliminate submissions of information that are not necessary either to conduct inspections of manufacturing facilities or to review the chemistry, manufacturing, and controls sections of Investigational New Drug Applications (INDs), New Drug Appliations, and abbreviated applications. The agency will no longer accept Type I DMFs or correspondence updating existing Type I DMFs.

The Center for Biologics Evaluation and Research (CBER) believes that for certain biological products, such as gene therapy products, review of some information that has previously been submitted in Type I DMFs is necessary to assess their safety for use in clinical trials under IND. CBER will accept this information for such products in Type V Master Files. On July 10, 2000, the effective date of this final rule, CBER intends to administratively recategorize current Type I Master Files that are still needed to other Master File Types as appropriate. Applicants who have current approved applications that reference Type I DMFs transferred to Type V DMFs may notify the agency of this change in an annual report as provided in 21 CFR 601.12.

Below is a table containing the tracking number (BBIND), and name and address of the sponsor for those Type I Master Files that CBER does not intend to recategorize and will close. If a holder of a Type I Master File believes that the Master File should be recategorized, the holder may contact the Division of Manufacturing and Product Quality (DMPQ) (HFM-207), Office of Compliance and Biologics Quality, CBER, 1401 Rockville Pike, Rockville, MD 20852-1448. DMPQ may also be reached at 301-827-3031.

horizontal rule

Type 1 Master Files to be Closed Effective July 10, 2000

BBIND SPONSOR
81 Parke-Davis Warner Lambert Pharmaceutical Research Div
170 Tabor Rd,
Morris Plains, NJ
07950
279 SKF
1250 S. Collegeville Rd.
Collegeville, PA
19426-0989
1107 Beecham
Executive Offices
501 5th Street
Bristo, TN
37620
1532 Hoffmann-La Roche, Inc
340 Kingsland Street
Nutley, NJ
07110-1199
1585 Genentech, Incorporated
1 DNA Way
South San Francisco, CA 94080-4990
1631 AMF
Morehead Patterson Center
689 Hope Street
Stamford, CT
060907
1671 Parke-Davis Warner Lambert Pharmaceutical Research Div
170 Tabor Rd
Morris Plains, NJ
07950
2021 Ventrex
217 Read Street
P.O. Box 9731
Portland, ME
04104-5031
2149 Revlon Health
Rorer Pharmaceutical Corporation
500 Washington Drive
Fort Washington, PA
10934
2238 Karyon Technology
Charles River Biotechnical Services, Inc
251 Ballardvale Street
Wilmington, MA
01887
2598 Pharmacia & Upjohn
7000 Portage Road
Kalamazoo, MI
49001-0199
2714 Chas River Biotech
251 Ballardvale Street
Wilmington, MA
01887
2976 Dupont
Diagnostic Imaging Division
331 Treble Cove Road
North Biullerica, MA
01862
3148 Osterreichisches
Institut Fur Haemoderivate Ges. M.B.H.
Industriestrasse 67
A-1220 Vienna
Austria
3220 Fresenius Medical Care, North American
Two Ledgemont Center
95 Hayden Avenue
Lexington, MA
02420
3225 Stolle Research
2964 Street
Route 42 South
Lebanon, OH
45036
3255 Hoffmann-Laroche, Inc
340 Kingsland Street
Nutley, NJ
07110-1199
3381 Oros Instruments
715 Banbury Avenue
Slough, SL 41J
United Kingdom
4183 Sandoz Ltd
Pharmaceutical Division
CH-4002
Basle, Switzerland
4479 Charles River Div of Wilmington Partners LP
251 Ballardvale Street
Wilmington, MA
01887
4830 Gensia Labs, Ltd
19 Hughes
Irvine, CA
92718-1902
5339 Bachem California
3132 Kashiwa Street
Torrance, CA
90505
5644 Merck Frosst Canada Inc
P.O. Box 1005
Pointe-Claire-Dorval
Quebec, H9R 4P8
Canada
5655 Unisyn Technologies, Inc
25 South Street, Suite E
Hopkinton, MA
01748
5717 Nutritional Products Group, New Zealand Dairy Board
Nutritional Products Group
25 The Terrace
P O Box 417
Wellington
New Zealand
5719 Nutritional Products Group, New Zealand Dairy Board
Nutritional Products Group
25 The Terrace
P O Box 417
Wellington
New Zealand
5720 Nutritional Products Group, New Zealand Dairy Board
Nutritional Products Group
25 The Terrace
P O Box 417
Wellington
New Zealand
5721 Nutritional Products Group, New Zealand Dairy Board
Nutritional Products Group
25 The Terrace
P O Box 417
Wellington
New Zealand
7126 Q-One Biotech Ltd
Todd Campus
West of Scotland Science Park
Glasgow, G20 OXA
UK

horizontal rule

FOR FURTHER INFORMATION CONTACT:

Robert A. Yetter
Center for Biologics Evaluation and Research (HFM-10),
Food and Drug Administration,
1401 Rockville Pike, Rockville, MD 20852-1448,
301-827-0373

 

 
horizontal rule